HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects
Open Access
- 1 November 2007
- journal article
- review article
- Published by Elsevier in Journal of Lipid Research
- Vol. 48 (11), 2325-2333
- https://doi.org/10.1194/jlr.r700011-jlr200
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytesBiochemical and Biophysical Research Communications, 2007
- Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-PhosphateScience, 2007
- Erythrocytes store and release sphingosine 1‐phosphate in bloodThe FASEB Journal, 2007
- Extracellular Export of Sphingosine Kinase-1 EnzymeJournal of Biological Chemistry, 2002
- Sphingosine 1-Phosphate May Be a Major Component of Plasma Lipoproteins Responsible for the Cytoprotective Actions in Human Umbilical Vein Endothelial CellsJournal of Biological Chemistry, 2001
- Sphingosine 1-phosphate: synthesis and releaseProstaglandins & Other Lipid Mediators, 2001
- Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actionsBiochemical Journal, 2000
- Metabolism and functional effects of sphingolipids in blood cellsBritish Journal of Haematology, 1999
- Evidence That Lipoproteins Are Carriers of Bioactive FactorsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Sphingosine 1-Phosphate, a Bioactive Sphingolipid Abundantly Stored in Platelets, Is a Normal Constituent of Human Plasma and SerumThe Journal of Biochemistry, 1997